Brooks-LaSure: Medicare poised to re-evaluate coverage of new Alzheimer’s drugs
By
Alicia Lasek
Dec 12, 2022
In a Milken Institute summit session, the CMS administrator said that Medicare’s door is open to evaluating new data on emerging Alzheimer’s drug candidates.
New model predicts five-year Alzheimer dementia risk
Oct 12, 2022
Model includes demographic information, brain imaging test results, and genetic biomarkers
Researchers receive $47M grant to study Alzheimer’s disease
By
John Roszkowski
Sep 26, 2022
Researchers from the University of California, Irvine have been awarded a $47 million grant from the National Institute on Aging to develop animal models to study the biology behind Alzheimer’s disease.
COVID-19 patients face higher risk of neurodegenerative disorders: study
By
Alicia Lasek (f3)
Jul 01, 2022
People who test positive for COVID-19 are at an increased risk of Alzheimer’s disease, Parkinson’s disease and ischemic stroke, a large new study finds.
How to better diagnose cognitive health? Up size and variety of drawing tasks, study shows
By
Alicia Lasek (f3)
Jul 01, 2022
Clinicians can more accurately classify a patient’s cognitive health status by increasing the number and variety of diagnostic drawing tasks, investigators report.
Most women unaware of their Alzheimer’s risk, Cleveland Clinic survey finds
By
Alicia Lasek (f3)
Jun 30, 2022
Fully 82% of U.S. women are unaware of their relatively high odds of developing Alzheimer’s disease. And most have not addressed key risk factors with a healthcare provider.
Clinical briefs for Thursday, April 7
By
Amy Novotney
Apr 07, 2022
Virtual dementia care program leads to 60% reduction in hospital admissions: study … Biden Administration accelerates effort to prevent, detect and treat Long COVID … BA.2 now behind 72% of all US...
Clinical briefs for Friday, Feb. 18
By
Amy Novotney
Feb 18, 2022
CDC reforming COVID-19 guidance … Nearly three-quarters of the U.S. now estimated to be immune to omicron variant … Brain synapse destruction culprit behind Alzheimer’s cognitive decline … Treatment...
Gait speed slows long before dementia diagnosis, 15-year study finds
By
Alicia Lasek
Feb 11, 2022
Slowing gait speed may signal the onset of dementia up to nine years before cognitive decline becomes evident, investigators say. It’s also linked to Alzheimer’s-related brain changes.
Study: ‘Cognitive frailty’ may be result of aging — not the brain changes found in dementia
By
Alicia Lasek
Jan 11, 2022
Reduced cognitive function without substantial memory complaints may be a normal part of aging and not an early sign of Alzheimer’s disease or other dementias, investigators say.